Literature DB >> 11074829

Lymphocytic infiltration in undifferentiated nasopharyngeal cancer.

A Jayasurya1, B H Bay, W M Yap, N G Tan.   

Abstract

BACKGROUND: Undifferentiated nasopharyngeal carcinoma (NPC) is characterized by prominent lymphocytic infiltration. Although the lymphoid infiltrate in NPC has been examined extensively in morphologic and immunocytochemical studies, the significance of this lymphoid infiltrate and its correlation with prognosis has been a subject of controversy for years.
OBJECTIVE: To elucidate the significance of lymphoid infiltration in undifferentiated NPC.
DESIGN: Evaluation of the relationship between lymphocytic infiltration in NPC and cervical lymph node status, ultrastructural examination of the lymphoid infiltrate, and assessment of lymphocytic infiltration as an independent prognosticator of regional node metastasis.
MATERIALS AND METHODS: Lymphocytic infiltration was evaluated quantitatively in 20 cases of undifferentiated NPC using light microscopy. Four cases of undifferentiated NPC were processed for conventional electron microscopy. The effects of degree of lymphocytic infiltration, age, and tumor stage on cervical nodal metastasis were analysed using the logistic regression model.
RESULTS: The degree of lymphoid infiltration correlated with cervical nodal metastasis (P<.001). Ultrastructural evidence of lymphocytes destroying cancer cells was seen. Lymphocytic infiltration was found to be an independent factor affecting cervical nodal metastasis (P =.02, univariate analysis; P =.03, multivariate analysis).
CONCLUSIONS: The lymphoid infiltrate is beneficial in undifferentiated NPC, and its presence may deter regional metastasis of cancer cells to the cervical nodes.

Entities:  

Mesh:

Year:  2000        PMID: 11074829     DOI: 10.1001/archotol.126.11.1329

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Barrett's esophageal carcinoma consisting of undifferentiated carcinoma and differentiated adenocarcinoma: report of case.

Authors:  Otohiro Katsube; Shin Saito; Yoshinori Hosoya; Toshihide Komatsubara; Takashi Ui; Kentaro Kurashina; Hidenori Haruta; Toru Zuiki; Takehiko Yamaguchi; Naohiro Sata; Yoshikazu Yasuda
Journal:  Clin J Gastroenterol       Date:  2013-03-31

2.  Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.

Authors:  E K Hoebe; S H Hutajulu; J van Beek; S J Stevens; D K Paramita; A E Greijer; J M Middeldorp
Journal:  Clin Vaccine Immunol       Date:  2010-12-01

3.  Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression.

Authors:  Danielle J Fassler; Luke A Torre-Healy; Rajarsi Gupta; Alina M Hamilton; Soma Kobayashi; Sarah C Van Alsten; Yuwei Zhang; Tahsin Kurc; Richard A Moffitt; Melissa A Troester; Katherine A Hoadley; Joel Saltz
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

4.  The Relationship between Tumor-infiltrating Lymphocytes (TILs) and Nasopharyngeal Carcinoma (NPC): A Systematic Review.

Authors:  Awal Prasetyo; Jethro Budiman; Udadi Sadhana
Journal:  Iran J Otorhinolaryngol       Date:  2021-07

5.  Discovery of recurrent structural variants in nasopharyngeal carcinoma.

Authors:  Anton Valouev; Ziming Weng; Robert T Sweeney; Sushama Varma; Quynh-Thu Le; Christina Kong; Arend Sidow; Robert B West
Journal:  Genome Res       Date:  2013-11-08       Impact factor: 9.043

Review 6.  The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.

Authors:  Maria Li Lung; Arthur Kwok Leung Cheung; Josephine Mun Yee Ko; Hong Lok Lung; Yue Cheng; Wei Dai
Journal:  Chin J Cancer       Date:  2014-11

Review 7.  BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.

Authors:  Eveline K Hoebe; Tessa Y S Le Large; Astrid E Greijer; Jaap M Middeldorp
Journal:  Rev Med Virol       Date:  2013-08-31       Impact factor: 6.989

8.  Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area.

Authors:  Zhengbo Wei; Xianjie Zeng; Jian Xu; Xuwei Duan; Ying Xie
Journal:  Onco Targets Ther       Date:  2014-05-15       Impact factor: 4.147

9.  The ratio of weight loss to planning target volume significantly impacts setup errors in nasopharyngeal cancer patients undergoing helical tomotherapy with daily megavoltage computed tomography.

Authors:  Wei-Hsien Hou; Chun-Wei Wang; Chiao-Ling Tsai; Feng-Ming Hsu; Jason Chia-Hsien Cheng
Journal:  Radiol Oncol       Date:  2016-09-08       Impact factor: 2.991

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.